Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Appointed director
CC transcript
|
|
NPS PHARMACEUTICALS INC (NPSP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/17/2015 |
SC 13G/A
| JANUS CAPITAL MANAGEMENT LLC reports a 5.7% stake in NPS PHARMACEUTICALS, INC. |
| 02/17/2015 |
SC 13G/A
| ING GROEP NV reports a 0% stake in NPS Pharmaceuticals, Inc. |
| 02/13/2015 |
SC 13G/A
| WELLS FARGO & COMPANY reports a 2% stake in NPS PHARMACEUTICALS INC |
| 02/13/2015 |
SC 13G/A
| FMR LLC reports a 15% stake in NPS PHARMACEUTICALS INC |
| 02/12/2015 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 8.2% stake in NPS Pharmaceuticals, Inc. |
| 02/10/2015 |
SC 13G/A
| VANGUARD GROUP INC reports a 5.6% stake in NPS Pharmaceuticals Inc |
| 02/10/2015 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 3.1% stake in NPS Pharmaceuticals, Inc. |
| 02/10/2015 |
SC 13G/A
| FMR LLC reports a 4.3% stake in NPS PHARMACEUTICALS INC |
| 01/29/2015 |
SC 13G/A
| BlackRock Inc. reports a 6.8% stake in NPS PHARMACEUTICALS INC |
| 02/14/2014 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 6.4% stake in NPS Pharmaceuticals, Inc. |
| 02/14/2014 |
SC 13G/A
| FMR LLC reports a 15% stake in NPS Pharmaceuticals Incorporated |
| 02/12/2014 |
SC 13G/A
| VANGUARD GROUP INC reports a 5.5% stake in NPS Pharmaceuticals Inc |
| 02/03/2014 |
SC 13G/A
| COLUMBIA WANGER ASSET MANAGEMENT LLC reports a |
| 01/29/2014 |
SC 13G/A
| BlackRock Inc. reports a 6.7% stake in NPS PHARMACEUTICALS INC. |
| 10/10/2013 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 5.4% stake in NPS Pharmaceuticals, Inc. |
| 03/07/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 03/12/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2012 |
SC 13G/A
| NPS PHARMACEUTICALS INC reports a 15% stake in NPS Pharmaceuticals Incorporated |
| 02/13/2012 |
SC 13G/A
| NPS PHARMACEUTICALS INC reports a 5.8% stake in NPS PHARMACEUTICALS INC |
| 02/10/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2012 |
SC 13G/A
| NPS PHARMACEUTICALS INC reports a 13.6% stake in NPS PHARMACEUTICALS, INC. |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2011 |
SC 13G/A
| RENAISSANCE TECHNOLOGIES LLC reports a 3.1% stake in NPS PHARMACEUTICALS, INC |
| 02/10/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/12/2010 |
SC 13G/A
| Visium Asset Management, LP reports a 9% stake in NPS Pharmaceuticals |
| 02/12/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/12/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 03/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/17/2009 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in NPS PHARMACEUTICALS, INC. |
| 02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
|
|
|